Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a <i>de novo</i> phenomenon

13 Jul 2016

Abstract excerpt

// Kanwal Raghav 1 , Van Morris 1 , Chad Tang 2 , Pia Morelli 1 , Hesham M. Amin 3 , Ken Chen 4 , Ganiraju C. Manyam 4 , Bradley Broom 4 , Michael J. Overman 1 , Kenna Shaw 5 , Funda Meric-Bernstam 6 , Dipen Maru 3 , David Menter 1 , Lee M. Ellis 7 , Cathy Eng 1 , David Hong 6 , Scott Kopetz 1 1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Liver physiology and pathology
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27421137
DOI: 10.18632/oncotarget.10559

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a <i>de novo</i> phenomenonPMID 27421137Read ↗

<i>MET</i> amplification as a potential therapeutic target in gastric cancerSemantic proximity Read ↗

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.Semantic proximity Read ↗

Clinical Implications of <i>MET</i> Gene Copy Number in Lung CancerSemantic proximity Read ↗

Targeting MET Dysregulation in CancerSemantic proximity Read ↗

Amplification of <i>MET</i> may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752Semantic proximity Read ↗

<i>MET</i> and <i>KRAS</i> Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase InhibitorsSemantic proximity Read ↗

The coexistence of MET over-expression and an <i>EGFR</i> T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancerSemantic proximity Read ↗

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerSemantic proximity Read ↗

Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer.Semantic proximity Read ↗

MET-TKIs selectively inhibit growth of hepatobiliary carcinoma harboring high copy number MET amplification: 2 cases and literature reviewSemantic proximity Read ↗

Untying the gordion knot of targeting MET in cancer.Semantic proximity Read ↗

MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.